Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernard Goichot

Showing results (121-130 of 133) with videos related to

Pageof 14
Sort By:
Medicina (Kaunas, Lithuania)|March 29, 2023
Pituitary Abscess: A Challenging Preoperative Diagnosis-A Multicenter StudyCharles-Henry Mallereau, Julien Todeschi, Mario Ganau, et al.
Lancet (London, England)|February 25, 2024
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trialEric Baudin, Bernard Goichot, Alfredo Berruti, et al.
Endocrine-Related Cancer|January 4, 2015
Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequencesIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Acta Neuropathologica|May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2014
Ketoconazole in Cushing's disease: is it worth a try?Frederic Castinetti, Laurence Guignat, Pauline Giraud, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2019
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaAlexandre Buffet, Laurène Ben Aim, Sophie Leboulleux, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2019
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective StudySegolene Hescot, Maria Curras-Freixes, Timo Deutschbein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2026
Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical CarcinomasRossella Libé, Matthieu Faron, Anne-Sophie Foucan, et al.
Endocrine-Related Cancer|September 22, 2016
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegalyIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Human Molecular Genetics|February 5, 2013
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort studyJulien Thevenon, Abderrahmane Bourredjem, Laurence Faivre, et al.
Pageof 14

Showing results (121-130 of 133) with videos related to

Sort By:
Pageof 14
Medicina (Kaunas, Lithuania)|March 29, 2023
Pituitary Abscess: A Challenging Preoperative Diagnosis-A Multicenter StudyCharles-Henry Mallereau, Julien Todeschi, Mario Ganau, et al.
Lancet (London, England)|February 25, 2024
Sunitinib for metastatic progressive phaeochromocytomas and paragangliomas: results from FIRSTMAPPP, an academic, multicentre, international, randomised, placebo-controlled, double-blind, phase 2 trialEric Baudin, Bernard Goichot, Alfredo Berruti, et al.
Endocrine-Related Cancer|January 4, 2015
Pituitary MRI characteristics in 297 acromegaly patients based on T2-weighted sequencesIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Acta Neuropathologica|May 17, 2024
Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumorsAndrew L Lin, Vasilisa A Rudneva, Allison L Richards, et al.
The Journal of Clinical Endocrinology and Metabolism|January 30, 2014
Ketoconazole in Cushing's disease: is it worth a try?Frederic Castinetti, Laurence Guignat, Pauline Giraud, et al.
The Journal of Clinical Endocrinology and Metabolism|January 31, 2019
Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or PheochromocytomaAlexandre Buffet, Laurène Ben Aim, Sophie Leboulleux, et al.
The Journal of Clinical Endocrinology and Metabolism|February 5, 2019
Prognosis of Malignant Pheochromocytoma and Paraganglioma (MAPP-Prono Study): A European Network for the Study of Adrenal Tumors Retrospective StudySegolene Hescot, Maria Curras-Freixes, Timo Deutschbein, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 14, 2026
Impact of the French ENDOCAN-COMETE Network on Overall Survival in Rare Adrenocortical CarcinomasRossella Libé, Matthieu Faron, Anne-Sophie Foucan, et al.
Endocrine-Related Cancer|September 22, 2016
T2-weighted MRI signal predicts hormone and tumor responses to somatostatin analogs in acromegalyIulia Potorac, Patrick Petrossians, Adrian F Daly, et al.
Human Molecular Genetics|February 5, 2013
Higher risk of death among MEN1 patients with mutations in the JunD interacting domain: a Groupe d'etude des Tumeurs Endocrines (GTE) cohort studyJulien Thevenon, Abderrahmane Bourredjem, Laurence Faivre, et al.
Pageof 14